The effects of angiotensin-converting enzyme inhibitors on the fibrous envelope around mammary implants

Plastic and Reconstructive Surgery

Volumn 120, Issue 7, 2007, Pages 2025-2033

  Zimman, Oscar A ^a   Toblli, Jorge ^b   Stella, Inés ^b   Ferder, Marcelo ^b   Ferder, Leon ^b   Inserra, Felipe ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 3; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRINKING WATER; ENALAPRIL; EOSIN; HEMATOXYLIN; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BREAST ENDOPROSTHESIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FIBROSIS; INFLAMMATION; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STAINING; SURFACE PROPERTY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BREAST IMPLANTS; COLLAGEN TYPE III; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; ENALAPRIL; EQUIPMENT DESIGN; FEMALE; FIBROSIS; GRANULOMA, FOREIGN-BODY; IMPLANTS, EXPERIMENTAL; MAMMARY GLANDS, ANIMAL; POSTOPERATIVE COMPLICATIONS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 37349073091     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000287381.93729.e2     Document Type: Article

References (48)

1. Handel, N., Jensen, J. A., Black, Q., Waisman, J. R., and Silverstein, M. J. The fate of breast implants: A critical analysis of complications and outcomes. Plast. Reconstr. Surg. 96: 1521, 1995.
2. Embrey, M., Adams, E. E., Cunningham, B., Peters, W., Young, V. L., and Carlo, G. L. A review of the literature on the etiology of capsular contracture and a pilot study to determine the outcome of capsular contracture interventions. Aesthetic Plast. Surg. 23: 197, 1999.
3. Gabbiani, G., Ryan, G. B., and Majno, G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 27: 549, 1971.
4. Domanskis, E. J., Jr., and Owsley, J. Q. Histological investigation of the etiology of capsule contracture following augmentation mammaplasty. Plast. Reconstr. Surg. 58: 689, 1976.
5. Zimman, O. A., Robles, J. M., and Lee, J. C. The fibrous envelope around mammary implants: An investigation. Aesthetic Plast. Surg. 2: 217, 1978.
6. Lanari, A., Quesada, A., and Paz, R. A. Sorprendente efecto de la progesterona en un caso de fibromatosis mediastinal. Medicina (B. Aires) 36: 281, 1976.
7. Lanari, A., Molinas, F. C., Castro Rios, M., and Paz, R. A. Eficaz tratamiento de diversas fibromatosis con progesterona. Mediastinitis fibrosa, tumores desmoides, fibrosis paraneoplásica. Medicina (B. Aires) 38: 123, 1978.
8. Zimman, O. A., Frider, B., Spiner, E. R., and Kien, M. Efecto de la progesterona sobre la envoltura fibrosa en torno a los implantes protésicos de mama. Rev. Argent. Cir. 50: 327, 1986.
9. Mazaheri, M. K., Schultz, G. S., Blalock, T. D., Caffee, H. H., and Chin, G. A. Role of connective tissue growth factor in breast implant elastomer capsular formation. Ann. Plast. Surg. 50: 263, 2003.
10. Ferder, L., Inserra, F., Romano, L., Ercole, L., and Pzenny, V. Decreased glomerulosclerosis in aging by angiotensin converting enzyme inhibitors. J. Am. Soc. Nephrol. 5: 1147, 1994.
11. Inserra, F., Romano, L., de Cavanagh, M. V., Ercole, L., and Ferder, L. Renal interstitial sclerosis in aging: Effects of enalapril and nifedipine. J. Am. Soc. Nephrol. 7: 676, 1996.
12. Ferder, L. F., Inserra, F., and Basso, N. Advances in our understanding of aging: Role of the renin-angiotensin system. Curr. Opin. Pharmacol. 2: 189, 2002.
13. Ferder, L. F., Inserra, F., and Basso, N. Effects of renin-angiotensin system blockade in the aging kidney. Exp. Gerontol. 38: 237, 2003.
14. de Cavanagh, E. M., Inserra, F., Toblli, J., Stella, I., Fraga, C. G., and Ferder, L. Enalapril attenuates oxidative stress in diabetic rats. Hypertension 38: 1130, 2001.
15. Toblli, J. E., Ferder, L., Stella, I., Angerosa, M., and Inserra, F. Enalapril prevents fatty liver in nephrotic rats. J. Nephrol. 15: 358, 2002.
16. Toblli, J. E., Stella, I., de Cavanagh, E. M., Angerosa, M., Inserra, F., and Ferder, L. Enalapril prevents tubulointerstitial lesions by hyperoxaluria. Hypertension 33: 225, 1999.
17. Zimman, O. A., Inserra, F., Toblli, J., Stella, I., and Ferder, L. The effects of angiotensin-converting enzyme inhibitors on the fibrous envelope around mammary implants (Abstract). Plast. Surg. Forum 25: 122, 2002.
18. Virden, C. P., Dobke, M. K., Stein, P., Parsons, C. L., and Frank, D. H. Subclinical infection of the silicone breast implant surface as a possible cause of capsular contracture. Aesthetic Plast. Surg. 16: 173, 1992.
19. Netscher, D. T., Weizer, G., Wigoda, P., Walker, L. E., Thornby, J., and Bowen, D. Clinical relevance of positive breast periprosthetic cultures without overt infection. Plast. Reconstr. Surg. 96: 1125, 1995.
20. Granchi, D., Cavedagna, D., Ciapetti, G., et al. Silicone breast implants: The role of immune system on capsular contracture formation. J. Biomed. Mater. Res 29: 197, 1995.
21. Kamel, M., Protzner, K., Fornasier, V., Peters, W., Smith, D., and Ibanez, D. The peri-implant breast capsule: An immunophenotypic study of capsules taken at explantation surgery. J. Biomed. Mater. Res. 58: 88, 2001.
22. Leask, A., and Abraham, D. J. TGF-β signaling and the fibrotic response. F.A.S.E.B. J. 18: 816, 2004.
23. Gabbiani, G. The myofibroblast in wound healing and fibroconnective disease. J. Pathol. 200: 500, 2003.
24. Liu, W., Wang, D. R., and Cao, Y. L. TGF-beta: A fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy. Curr. Gene Ther. 4: 123, 2004.
25. Gholami, S. S., Gonzalez-Cadavid, N. F., Lin, C. S., Rajfer, J., and Lue, T. F. Peyronie's disease: A review. J. Urol. 169: 1234, 2003.
26. Bartram, U., and Speer, C. P. The role of transforming growth factor beta in lung development and disease. Chest 125: 754, 2004.
27. Schnaper, H. W., Hayashida, T., Hubchak, S. C., and Poncelet, A. C. TGF-beta signal transduction and mesangial cell fibrogenesis. Am. J. Physiol. 284: F243, 2003.
28. Gupta, S., Clarkson, M. R., Duggan, J., and Brady, H. R. Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int. 58: 1389, 2000.
29. Shah, M., Foreman, D. M., and Ferguson, M. W. J. Control of scarring in adult wounds by neutralizing antibody to transforming growth factor β. Lancet 339: 213, 1992.
30. Kuhn, A., Singh, S., Smith, P. D., et al. Periprosthetic breast capsules contain the fibrogenic cytokines TGF-β1 and TGF-β2, suggesting possible new treatment approaches. Ann. Plast. Surg. 44: 387, 2000.
31. Chin, G. A., Mazaheri, M., Blalock, T., Caffee, H. H., and Schultz, G. Role of CTGF in breast implant elastomer capsular formation (Abstract). Plast. Surg. Forum 25: 31, 2002.
32. Ruiz de Erenchun, R. Utilización del péptido inhibidor de TGF-β1 en fibrosis capsular periprotesica (Abstract). Presented at the XV Congress of FILACP, Sevilla, Spain, May 7-11, 2004.
33. Ruiz de Erenchun, R., Dotor de las Herrerias, J., and Hontanilla, B. Use of the transforming growth factor-[beta] 1 inhibitor peptide in periprosthetic capsular fibrosis: Experimental model with tetraglycerol dipalmitate. Plast. Reconstr. Surg. 116: 1370, 2005.
34. Hakelius, L., and Ohlsén, L. Tendency to capsular contracture around smooth and textured gel-filled silicone mammary implants: A 5-year follow-up. Plast. Reconstr. Surg. 100: 1566, 1997.
35. Suzuki, Y., Ruiz-Ortega, M., and Egido, J. Angiotensin II: A double-edged sword in inflammation. J. Nephrol. 13: S101, 2000.
36. Klahr, S., Schreiner, G., and Ichikawa, I. The progression of renal disease. N. Engl. J. Med. 318: 1657, 1988.
37. Ferder, L., Inserra, F., and Martínez-Maldonado, M. Inflammation and the metabolic syndrome: Role of angiotensin II and oxidative stress. Curr. Hypertens. Rep. 8: 191, 2006.
38. Pinzani, M., Marra, F., and Carloni, V. Signal transduction in hepatic stellate cells. Liver 18: 2, 1998.
39. Toblli, J. E., Ferder, L., Stella, I., de Cavanagh, E. M., Angerosa, M., and Inserra, F. Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. J. Urol. 168: 1550, 2002.
40. Agarwal, R., Campbell, R. C., and Warnock, D. G. Oxidative stress in hypertension and chronic kidney disease: Role of angiotensin II. Semin. Nephrol. 2: 101, 2004.
41. Yanagitani, Y., Rakugi, H., Okamura, A., et al. Angiotensin II type 1 receptor-mediated peroxide production in human macrophages. Hypertension 33: 335, 1999.
42. Griendling, K. K., Sorescu, D., Lassegue, B., and Ushio-Fukai, M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler. Thromb. Vasc. Biol. 10: 2175, 2000.
43. de Cavanagh, E. M., Inserra, F., Ferder, L., and Fraga, C. G. Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues. Am. J. Physiol. 278: R572, 2000.
44. de Cavanagh, E. M., Fraga, C. G., Ferder, L., and Inserra, F. Enalapril and captopril enhance antioxidant defenses in mouse tissues. Am. J. Physiol. 272: R514, 1997.
45. de Cavanagh, E. M., Inserra, F., Ferder, L., Romano, L., Ercole, L., and Fraga, C. G. Superoxide dismutase and glutathione peroxidase activities are increased by enalapril and captopril in mouse liver. F.E.B.S. Lett. 361: 22, 1995.
46. Toblli, J. E., Stella, I., Mazza, O. N., Ferder, L., and Inserra, F. Different effect of losartan and amlodipine on penile structures in male spontaneously hypertensive rats. Am. J. Nephrol. 24: 614, 2004.
47. Kagami, S., Border, W. A., Miller, D. E., and Noble, N. A. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor beta-1 expression in rat glomerular mesangial cells. J. Clin. Invest. 93: 2431, 1994.
48. Klahr, S., and Morrisey, J. J. Angiotensin II and gene expression in the kidney. Am. J. Kidney Dis. 31: 171, 1998.